DAPUS

1. Uhing MR. The albumin controversy. Clin Perinatol 2004; 31: 475-88
2. Cochrane Injuries Group Albumin Reviewers. Human albumin administration
in critically ill patients: systematic review of randomised controlled
trials. BMJ 1998; 317: 235-40
3. Avindan B.The use of albumin in all patient with decompensated cirrhosis is
not justified. IMAJ 2005; 7: 118-20
4. Gines P, Arroyo V. Is there still a need for albumin infusions to treat patients
with liver disease? Gut 2000; 46: 588-90
5. Peters TJ. The albumin molecule: Its structure and chemical properties. In: All
about albumin. Biochemistry, genetics, and medical applications. San Diego:
Academic Press; 1996.p. 9-756.
6. Evans WT. Review article: Albumin as a drug-biological effects of albumin
unrelated to oncotic pressure. Aliment Pharmacol Ther 2002; 16 (Suppl.5): 611
7. Gonzales ER, Kannewurf B. The clinical use of albumin. US Pharmacist 1998;
23: HS15-26
8. Wong F. Nat Clin Pract Gastroenterol Hepatol. 2007 Jan; 4(1):43-51
9. Evans TW. Aliment Pharmacol Ther. 2002 Dec; 16 (Suppl. 5): 6-11.
10. Kragh-Hansen U, Chuang VT, Otagiri M. Practical aspects of the ligand
binding and enzymatic properties of human serum albumin. Biol Pharm Bull.
2002;25:695704
11. Quinlan GJ, Martin GS, Evans TW. Albumin: biochemical properties and
therapeutic potential. Hepatology. 2005;41:12111219
12. Arroyo V. Review article: albumin in the treatment of liver diseases-new
features of a classical treatment. Aliment Pharmacol Ther 2002; 16 (Suppl. 5):
1-5
13. Konsensus FKUI-PPHI. Pemberian albumin pada sirosis hati. Unit
PPKB/CME FKUI 2003.p.1-6
14. De Mattos A, Alves. Current indications for the use of albumin in the
treatment of cirrhosis. Ann Hepatol. 2011 May; 10 (Suppl. 1): 15-20
15. Follo A, Llovet JM, Navasa M, et al. Renal impairment after spontaneous
bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors
and prognosis. Hepatology 1994; 20:1495-501
16. Guarner C, Runyon BA. Spontaneous peritonitis: pathogenesis, diagnosis, and
management. Gastroenterologist 1995; 3:311
17. Sort P, Nasava M, Arroyo V, et al. Effect of intravenous albumin on renal
impairment and mortality in patient with cirrhosis and spontaneous bacterialis
peritonitis. N Engl J M 1999; 341:403-9.
18. Arroyo P, Terra C, Gines P. Advances in the pathogenesis and treatment of
type-1 and type-2 hepatorenal syndrome. J Hepatol 2007; 46:935-46 14.
19. Duvoux C, Zanditenas D, Hezode C, Chaucat A, Monin JL, et al. Effects of
noradrenalin and albumin in patients with type 1 hepatorenal syndrome: A
pilot study. Hepatology 2002; 36:374-80
20. Ortega R, Gines P, Uriz J, Cardenas A, Calahorra B, Heras DDL. Terlipressin
with and without albumin for patients with hepatorenal syndrome: Results of a
prospective, nonrandomized study. Hepatology 2002; 36:941- 48
21. Runyon BA. Management of adult patients with ascites due to cirrhosis
(AASLD Practice Guideline). Hepatology 2004; 39:1-16
22. Tito Ll, Gines P, Arroyo V, Planas R, Panes J, Rimola A. Total paracentesis

associated with intravenous albumin management of patients with cirrhosis

and ascites. Gastroenterology 1990; 98: 146-51.
23. Gines A, Fernandez-Esparrach G, Monescillo A, et al. Randomized trial
comparing albumin, dextran 70, and polygeline in cirrhotic patients treated by
paracentesis. Gastroenterology 1996; 111:1002-10
24. Sola-Vera J, Minana J, Ricart E, Planella M, Gonzalez B, et al. Randomized
trial comparing albumin and saline in the prevention of paracentesis-in- duced
circulatory dysfunction in cirrhotic patients with ascites. Hepatol- ogy 2003;
37:1147-53
25. Chalasani N, Gorski JC, Horlander JC, Craven R, Hoen H, et al. Effects of
albumin/furosemide mixtures on responses to furosemide in hypoalbuminemic patients. J Am Soc Nephrol 2001; 12:1010-16
26. Wilkinson P, Sherlock S. The effect of repeated albumin infusions in pa- tients
with cirrhosis. Lancet 1962; ii:1125-9
27. Gentilini P, Casini-Raggi V, Di Fiore G, Romanelli RG, Buzzelli G, Pinzani
M, et al. Albumin improves the response to diuretics in patients with cirrhosis
and ascites: results of a randomized, controlled trial. J Hepatol 199; 30:639-45
28. Romanelli R, Villa G, Barletta G, et al. Long term albumin infusion improves
survival in patients with cirrhosis and asites : An unblinded randomized trial.
World J Gastroenterol 2006;12(9):1403-7